Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
21/07/2026 23:34
BRIEF-Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing July 21 (Reuters) - Krystal Biotech Inc KRYS.O:
KRYSTAL BIOTECH - FILES RESPONSE WITH USPTO ON KB801 PATENT APPLICATION - SEC FILING
KRYSTAL BIOTECH - DISCONTINUES CLINICAL STUDY TO ADVANCE KB801 INTO PIVOTAL TRIAL; NO SAFETY CONCERNS OBSERVED - SEC FILING
KRYSTAL BIOTECH - NO FURTHER SUBJECT-LEVEL UPDATES FROM DISCONTINUED STUDY; PIVOTAL TRIAL RESULTS EXPECTED IN DUE COURSE - SEC FILING
Source text: [ID:n0001711279-26-000050]
Further company coverage: KRYS.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion